| 发明名称 |
OPTIMISED SUBCUTANEOUS THERAPEUTIC AGENTS. |
| 摘要 |
<p>Methods and dosage formulations are provided for subcutaneous administration in which therapeutic agents are modified to increase the hydrophilicity and molecular dimensions in relation to the native state of the therapeutic agent, in which the Cmax:Caverage ratio is lower than the Cmax:Caverage ratio of the agent when delivered intravenously.</p> |
| 申请公布号 |
MX2014012512(A) |
申请公布日期 |
2015.01.15 |
| 申请号 |
MX20140012512 |
申请日期 |
2013.04.16 |
| 申请人 |
CANTAB BIOPHARMACEUTICALS PATENTS LIMITED |
发明人 |
WILLIAM HENRY;RICHARD WOLF-GARRAWAY;JOHN CHARLES MAYO;MICHAEL JAMES EARL |
| 分类号 |
A61K47/48;A61P7/04;A61P31/00 |
主分类号 |
A61K47/48 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
